Dare Bioscience, Inc. (DARE) stock
DARENasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.43−0.16 (-26.57%)
Close on Nov 17, 2026Market cap $6.56MP/E –Yield –
Dare Bioscience total assets
Total assets on the balance sheet at the end of each period.
Dare Bioscience's total assets was $22.37M at Jun 30, 2026. For fiscal 2025 it was $32.47M, up 46.9% from the year before. Over ten years it grew -8.4% a year on average. The highest annual figure on record is $78.23M in fiscal 2015.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $32.47M | +46.9% |
| FY2024 | Dec 31, 2024 | $22.10M | +3.8% |
| FY2023 | Dec 31, 2023 | $21.28M | -51.4% |
| FY2022 | Dec 31, 2022 | $43.83M | -21.5% |
| FY2021 | Dec 31, 2021 | $55.81M | +639.1% |
| FY2020 | Dec 31, 2020 | $7.55M | +1.5% |
| FY2019 | Dec 31, 2019 | $7.44M | -4.9% |
| FY2018 | Dec 31, 2018 | $7.83M | -45.1% |
| FY2017 | Dec 31, 2017 | $14.26M | +31862.7% |
| FY2016 | Dec 31, 2016 | $44.61K | -99.9% |
| FY2015 | Dec 31, 2015 | $78.23M | +46.5% |
| FY2014 | Dec 31, 2014 | $53.39M | +682.1% |
| FY2013 | Dec 31, 2013 | $6.83M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $22.37M | +72.3% |
| Q1 FY2026 | Mar 31, 2026 | $27.83M | +49.5% |
| Q4 FY2025 | Dec 31, 2025 | $32.47M | +46.9% |
| Q3 FY2025 | Sep 30, 2025 | $30.75M | +70.3% |
| Q2 FY2025 | Jun 30, 2025 | $12.98M | -45.0% |
| Q1 FY2025 | Mar 31, 2025 | $18.62M | +43.1% |
| Q4 FY2024 | Dec 31, 2024 | $22.10M | +3.8% |
| Q3 FY2024 | Sep 30, 2024 | $18.06M | -27.9% |
| Q2 FY2024 | Jun 30, 2024 | $23.61M | +1.7% |
| Q1 FY2024 | Mar 31, 2024 | $13.01M | -57.1% |
| Q4 FY2023 | Dec 31, 2023 | $21.28M | -51.4% |
| Q3 FY2023 | Sep 30, 2023 | $25.05M | -50.3% |
| Q2 FY2023 | Jun 30, 2023 | $23.21M | -54.8% |
| Q1 FY2023 | Mar 31, 2023 | $30.37M | -38.3% |
| Q4 FY2022 | Dec 31, 2022 | $43.83M | -21.5% |
| Q3 FY2022 | Sep 30, 2022 | $50.38M | +3.2% |
| Q2 FY2022 | Jun 30, 2022 | $51.39M | +246.7% |
| Q1 FY2022 | Mar 31, 2022 | $49.19M | +367.6% |
| Q4 FY2021 | Dec 31, 2021 | $55.81M | +639.1% |
| Q3 FY2021 | Sep 30, 2021 | $48.81M | +537.1% |
| Q2 FY2021 | Jun 30, 2021 | $14.82M | +72.9% |
| Q1 FY2021 | Mar 31, 2021 | $10.52M | +3.0% |
| Q4 FY2020 | Dec 31, 2020 | $7.55M | +1.5% |
| Q3 FY2020 | Sep 30, 2020 | $7.66M | +97.4% |
| Q2 FY2020 | Jun 30, 2020 | $8.57M | +18.0% |
| Q1 FY2020 | Mar 31, 2020 | $10.21M | +103.5% |
| Q4 FY2019 | Dec 31, 2019 | $7.44M | -4.9% |
| Q3 FY2019 | Sep 30, 2019 | $3.88M | -64.0% |
| Q2 FY2019 | Jun 30, 2019 | $7.26M | -46.1% |
| Q1 FY2019 | Mar 31, 2019 | $5.02M | -69.8% |
| Q4 FY2018 | Dec 31, 2018 | $7.83M | -45.1% |
| Q3 FY2018 | Sep 30, 2018 | $10.80M | -53.6% |
| Q2 FY2018 | Jun 30, 2018 | $13.48M | +65.4% |
| Q1 FY2018 | Mar 31, 2018 | $16.63M | +4.2% |
| Q4 FY2017 | Dec 31, 2017 | $14.26M | +31862.7% |
| Q3 FY2017 | Sep 30, 2017 | $23.27M | -42.0% |
| Q2 FY2017 | Jun 30, 2017 | $8.15M | – |
| Q1 FY2017 | Mar 31, 2017 | $15.95M | – |
| Q4 FY2016 | Dec 31, 2016 | $44.61K | – |
| Q3 FY2016 | Sep 30, 2016 | $40.13M | – |
See a number that looks wrong?